The Catalysis Foundation for Health is a renowned organization that brings extensive expertise in the diagnostics industry, business knowledge, and product engineering to ensure the development and delivery of diagnostic tests that meet the specific requirements of local health practitioners in developing countries. Founded in 2007, the Catalysis Foundation is dedicated to addressing life-threatening infectious diseases and chronic conditions that prevail in the developing world. Their approach to diagnostics innovation in underserved markets involves three key steps.

Firstly, they thoroughly understand the clinical needs, commercial requirements, stakeholder relationships, and infrastructure limitations in target regions. Secondly, leveraging their global health initiatives and experience, they determine the necessary product specifications. Finally, they establish a coalition consisting of experts from various sectors to accelerate the transition from discovery to delivery of appropriate diagnostics.

Catalysis Foundation's flagship program focuses on enhancing Tuberculosis (TB) diagnostics to effectively determine therapy effectiveness. With over one-third of the world's population infected with the TB bacterium and the majority of cases occurring in developing countries, addressing the global unmet need for improved TB treatments is crucial. Overall, Catalysis Foundation plays a vital role in the development and delivery of diagnostic solutions, providing hope for better healthcare outcomes in underserved populations